{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:52:27Z","timestamp":1783691547259,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011758"],"award-info":[{"award-number":["2022A1515011758"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Guangdong Province Department of Education","doi-asserted-by":"publisher","award":["2022KTSCX029"],"award-info":[{"award-number":["2022KTSCX029"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.molimm.2025.02.006","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:37:40Z","timestamp":1740213460000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Artemisinin analogues are effective in the treatment of psoriasis by targeting ROR\u03b3t"],"prefix":"10.1016","volume":"180","author":[{"given":"Xuyan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5654-765X","authenticated-orcid":false,"given":"Fanrong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"xiaoxiao","family":"xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.02.006_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1538\/expanim.63.235","article-title":"Rag2-deficient IL-1 Receptor Antagonist-deficient Mice Are a Novel Colitis Model in Which Innate Lymphoid Cell-derived IL-17 Is Involved in the Pathogenesis","volume":"63","author":"Akitsu","year":"2014","journal-title":"Experimental animals"},{"key":"10.1016\/j.molimm.2025.02.006_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.15430\/JCP.2015.20.4.250","article-title":"Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin","volume":"20","author":"Anna","year":"2015","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.molimm.2025.02.006_bib3","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1096\/fj.14-254755","article-title":"Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective","volume":"28","author":"Ayroldi","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.molimm.2025.02.006_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","article-title":"The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications","volume":"5","author":"Beatrice","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.molimm.2025.02.006_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41419-018-0673-z","article-title":"Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation","volume":"9","author":"Bigas","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molimm.2025.02.006_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.molimm.2025.02.006_bib7","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T helper lymphocytes","volume":"56","author":"Chen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.molimm.2025.02.006_bib8","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.molimm.2025.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205340","article-title":"The small molecule rhodomyrtone suppresses TNF-\u03b1 and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis","volume":"13","author":"Chorachoo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.02.006_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis--epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2025.02.006_bib12","doi-asserted-by":"crossref","unstructured":"Crespo-Ortiz, M.P., Wei, M.Q., 2012. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. Journal of biomedicine & biotechnology 2012, 247597.","DOI":"10.1155\/2012\/247597"},{"key":"10.1016\/j.molimm.2025.02.006_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaad.2017.10.051","article-title":"Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study","volume":"78","author":"Descalzo","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137711","article-title":"Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing ROR\u03b3t Activity and Suppressing Th17 Cell Differentiation","volume":"10","author":"Ding","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.02.006_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2567.2008.02859.x","article-title":"Epidermal keratinocytes do not activate peripheral T-cells: interleukin-10 as a possible regulator","volume":"125","author":"Dom\u00ednguez-Castillo","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2025.02.006_bib16","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molimm.2025.02.006_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.23736\/S0392-0488.18.06202-8","article-title":"Psoriasis and the TNF\/IL23\/IL17 axis","volume":"154","author":"Furue","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.molimm.2025.02.006_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076145","article-title":"Loss of DAP12 and FcR\u03b3 drives exaggerated IL-12 production and CD8(+) T cell response by CCR2(+) Mo-DCs","volume":"8","author":"Gmyrek","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.molimm.2025.02.006_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib20","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.molimm.2025.02.006_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4172\/2155-9899.1000400","article-title":"IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases","volume":"7","author":"Guo","year":"2016","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: A comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.molimm.2025.02.006_bib23","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"The Journal of experimental medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2017.02.027","article-title":"Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice","volume":"140","author":"Honda","year":"2017","journal-title":"The Journal of allergy and clinical immunology"},{"key":"10.1016\/j.molimm.2025.02.006_bib25","article-title":"Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis","volume":"9","author":"Hou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.02.006_bib26","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.30392","article-title":"Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses","volume":"63","author":"Hou","year":"2011","journal-title":"Arthritis and rheumatism"},{"key":"10.1016\/j.molimm.2025.02.006_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB \u00d7 NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.molimm.2025.02.006_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing ROR\u03b3t activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2025.02.006_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.drudis.2014.04.012","article-title":"Inhibiting ROR\u03b3t\/Th17 axis for autoimmune disorders","volume":"19","author":"Isono","year":"2014","journal-title":"Drug discovery today"},{"key":"10.1016\/j.molimm.2025.02.006_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2025.02.006_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","article-title":"Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells","volume":"44","author":"Jain","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2025.02.006_bib32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","article-title":"In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing ROR\u03b3t and IL-17","volume":"134","author":"Keijsers","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib33","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.molimm.2025.02.006_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.imlet.2018.06.009","article-title":"Taking the lead - how keratinocytes orchestrate skin T cell immunity","volume":"200","author":"Klicznik","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.molimm.2025.02.006_bib35","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2007.135053","article-title":"IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn\u2019s disease","volume":"57","author":"Kobayashi","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.molimm.2025.02.006_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib38","first-page":"306","article-title":"Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo","volume":"16","author":"Li","year":"2013"},{"key":"10.1016\/j.molimm.2025.02.006_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation","volume":"6","author":"Li","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.molimm.2025.02.006_bib40","article-title":"Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell","volume":"8","author":"Li","year":"2013"},{"key":"10.1016\/j.molimm.2025.02.006_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.molimm.2025.02.006_bib42","first-page":"164","article-title":"Increased \u03b2TrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-\u03baB signaling pathway","volume":"592","author":"Li","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.molimm.2025.02.006_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib44","first-page":"441","article-title":"Effects of artesunate on immune function in mice","volume":"16","author":"Lin","year":"1995","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.molimm.2025.02.006_bib45","doi-asserted-by":"crossref","first-page":"704481","DOI":"10.3389\/fphar.2021.704481","article-title":"Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23\/Th17 Axis","volume":"12","author":"Liu","year":"2021","journal-title":"Frontiers in pharmacology"},{"key":"10.1016\/j.molimm.2025.02.006_bib46","first-page":"11","article-title":"From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature","author":"Lob\u00e3o","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.molimm.2025.02.006_bib47","doi-asserted-by":"crossref","unstructured":"Lorthois, I., Asselineau, D., Seyler, N., Pouliot, R., 2017. Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis. Mediators of inflammation 2017, 7215072.","DOI":"10.1155\/2017\/7215072"},{"key":"10.1016\/j.molimm.2025.02.006_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02684010","article-title":"Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction","volume":"51","author":"Lubberts","year":"2002","journal-title":"Inflammation Research"},{"key":"10.1016\/j.molimm.2025.02.006_bib49","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nature communications"},{"key":"10.1016\/j.molimm.2025.02.006_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2018.01.001","article-title":"Th17 cells, \u03b3\u03b4 T cells and their interplay in EAE and multiple sclerosis","volume":"87","author":"McGinley","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.molimm.2025.02.006_bib51","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib53","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"The Journal of experimental medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/exd.12896","article-title":"Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration","volume":"25","author":"Nelson","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2018.09.002","article-title":"Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis: A molecular insight","volume":"206","author":"Nguyen","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib56","article-title":"Serum amyloid A, an acute phase protein, stimulates proliferative and proinflammatory responses of keratinocytes","volume":"50","author":"Ning","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.molimm.2025.02.006_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.06.005","article-title":"Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes","volume":"53","author":"Okiyama","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.molimm.2025.02.006_bib59","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib60","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.3390\/ijms21228790","article-title":"The Immune Functions of Keratinocytes in Skin Wound Healing","volume":"21","author":"Piipponen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molimm.2025.02.006_bib61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/exd.12191","article-title":"Characterization of skin\u2010resident T cells using a crawl\u2010out method and flow cytometry","volume":"22","author":"Poot","year":"2013","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.12710","article-title":"Evidence that a neutrophil\u2013keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis","volume":"24","author":"Reich","year":"2015","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib63","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2010-01-263509","article-title":"Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells","volume":"116","author":"Schirmer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2025.02.006_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cell.2007.02.045","article-title":"p63 Is essential for the proliferative potential of stem cells in stratified epithelia","volume":"129","author":"Senoo","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2025.02.006_bib65","doi-asserted-by":"crossref","unstructured":"Shi, C., Li, H., Yang, Y., and Hou, L. (2015). Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives. Mediators Inflamm 2015, 435713-435713.","DOI":"10.1155\/2015\/435713"},{"key":"10.1016\/j.molimm.2025.02.006_bib66","first-page":"253","article-title":"Role of the IL-23\/IL-17 axis in Crohn\u2019s disease","volume":"14","author":"Siakavellas","year":"2012","journal-title":"Discovery Medicine"},{"key":"10.1016\/j.molimm.2025.02.006_bib67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/bies.20792","article-title":"What goes on behind closed doors: physiological versus pharmacological steroid hormone actions","volume":"30","author":"Simons","year":"2008","journal-title":"BioEssays"},{"key":"10.1016\/j.molimm.2025.02.006_bib68","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2559.2005.02260.x","article-title":"Histologic Diagnosis of Inflammatory Skin Diseases. An Algorithmic Method Based on Pattern Analysis","volume":"47","author":"Slater","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.molimm.2025.02.006_bib69","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2025.02.006_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH 17, the first major revision in the TH1\/TH2 hypothesis of T cell\u2013mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.molimm.2025.02.006_bib71","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jid.2021.05.019","article-title":"Treating Psoriasis with a Light Touch","volume":"141","author":"Sugaya","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib72","first-page":"268","article-title":"Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3","volume":"27","author":"Tang","year":"2018"},{"key":"10.1016\/j.molimm.2025.02.006_bib73","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fimmu.2018.01210","article-title":"Transcription Factor Retinoid-Related Orphan Receptor \u03b3t: A Promising Target for the Treatment of Psoriasis","volume":"9","author":"Tang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.02.006_bib74","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-022-00722-y","article-title":"Drug Survival of Interleukin (IL)\u201117 and IL\u201123 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi\u2011country, Multicentric Cohort Study","volume":"23","author":"Torres","year":"2022","journal-title":"American journal of clinical dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib75","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1101\/gad.1463206","article-title":"p63 regulates proliferation and differentiation of developmentally mature keratinocytes","volume":"20","author":"Truong","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.molimm.2025.02.006_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1104","article-title":"Pro-inflammatory cytokine IL-6 regulates LMO4 expression in psoriatic keratinocytes via AKT\/STAT3 pathway","volume":"11","author":"Tu","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.molimm.2025.02.006_bib77","doi-asserted-by":"crossref","unstructured":"Tu, Z., Wei, W., Zeng, F., Wang, W., Zhang, Y., Zhang, Y., Zhou, F., Cai, C., Zhang, S., and Zhou, H. (2024). IL-6 Up-Regulates Expression of LIM-Domain Only Protein 4 in Psoriatic Keratinocytes through Activation of the MEK\/ERK\/NF-\u03baB Pathway. Am J Pathol. 194.","DOI":"10.1016\/j.ajpath.2024.01.014"},{"key":"10.1016\/j.molimm.2025.02.006_bib78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod","volume":"41","author":"Ueyama","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib79","doi-asserted-by":"crossref","unstructured":"van der Fits, L., Mourits, S., Voerman, J.S., Kant, M., Boon, L., Laman, J.D., Cornelissen, F., Mus, A.M., Florencia, E., Prens, E.P., Lubberts, E., 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. Journal of immunology (Baltimore, Md. : 1950) 182, 5836-5845.","DOI":"10.4049\/jimmunol.0802999"},{"key":"10.1016\/j.molimm.2025.02.006_bib80","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/jid.2013.237","article-title":"IL-17 and TNF Synergistically Modulate Cytokine Expression while Suppressing Melanogenesis: Potential Relevance to Psoriasis","volume":"133","author":"Wang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.molimm.2025.02.006_bib81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","article-title":"Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation","volume":"150","author":"Wang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molimm.2025.02.006_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11101-010-9166-0","article-title":"Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases","volume":"10","author":"Weathers","year":"2011","journal-title":"Phytochemistry reviews\u202f: proceedings of the Phytochemical Society of Europe"},{"key":"10.1016\/j.molimm.2025.02.006_bib83","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1016\/j.molimm.2025.02.006_bib84","first-page":"927","article-title":"CD4+\u2009T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model","volume":"10","author":"Wu","year":"2019"},{"key":"10.1016\/j.molimm.2025.02.006_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopha.2018.11.092","article-title":"PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro- and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3","volume":"110","author":"Wu","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.molimm.2025.02.006_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-020-00578-0","article-title":"Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review","volume":"22","author":"Yang","year":"2021","journal-title":"American journal of clinical dermatology"},{"key":"10.1016\/j.molimm.2025.02.006_bib87","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2013.11.008","article-title":"Interleukin-22: a likely target for treatment of autoimmune diseases","volume":"13","author":"Yang","year":"2014","journal-title":"Autoimmunity reviews"},{"key":"10.1016\/j.molimm.2025.02.006_bib88","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.molimm.2025.02.006_bib89","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3389\/fimmu.2019.02679","article-title":"The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game","volume":"10","author":"Zhan","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib90","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1\/M2 Macrophage Ratio in Psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.molimm.2025.02.006_bib91","doi-asserted-by":"crossref","unstructured":"Zhao, Y.G., Wang, Y., Guo, Z., Gu, A.D., Dan, H.C., Baldwin, A.S., Hao, W., Wan, Y.Y., 2012. Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. Journal of immunology (Baltimore, Md. : 1950) 189, 4417-4425.","DOI":"10.4049\/jimmunol.1200919"},{"key":"10.1016\/j.molimm.2025.02.006_bib92","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T03:38:14Z","timestamp":1741491494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":92,"alternative-id":["S0161589025000409"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.02.006","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisinin analogues are effective in the treatment of psoriasis by targeting ROR\u03b3t","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}